Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis

摘要

The invention refers to medicine, namely to a pharmaceutical composition that may be used for prophylaxis and treatment of osteoporosis.Summary of the invention consists in that the pharmaceutical composition contains calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, where to a dose of calcium of 150…1500 mg, preferably of 200…600 mg, may be taken 100…1000 IU, preferably 400…900 IU of vitamin D, or 20…500 mg, preferably 150…300 mg of magnesium, wherein the active substances containing calcium and magnesium are finely grounded so that at least 80% of particles have dimensions under 75 µm and, moreover, contain conventional adjuvants and pharmaceutically acceptable derivatives of starch, preferably diphosphate starch in a quantity of 5…40 wt%, preferably of 15…25 wt%; substances of vegetal origin able to form xerogels with the water, preferably carragheenan, in a quantity of 0,1…1,0 wt%, preferably of 0,2…0,6 wt%.The aforesaid composition represents a quick-soluble powder, which at the addition of liquids, after a short mixing, form a pudding resembling gellylike suspension, well-tolerated by patients.